About this entry

We are a group of bioengineering researchers at Johns Hopkins University. Our group has been working on the development and implementation of microfluidic devices and biosensors for Point-of-Care diagnostics of infectious diseases for more than 10 years. In this project, we propose to develop and validate a rapid diagnostic platform capable of performing detection and assessment of antimicrobial resistance (AMR) of Neisseria gonorrhoeae (NG) within 20 minutes. Our device features not only high sensitivity and rapid turnaround time but also the power to report AMR profile, thereby addressing the unmet need for POC diagnostics and personalized treatment of NG. Our goal is to transform the clinical management of NG and to provide an easy-to-adopt solution to mitigate the increasing challenge in surveillance of AMR in NG.